Biotech Distilled
Substack ↗
Subscribe
Subscribe
Substack ↗
About
Research
Areas
Modalities
Phases
Targets
Catalysts
Filings
Track record
Movers
The Lead Compound
Home
›
Targets
› TRC105
TRC105
(1 companies · 1 programs)
Companies with an active program directed at TRC105.
Kairos Pharma, LTD.
KAPA
carotuximab
— Prostate Cancer
Phase 2